Guryanov I., Orlandin A., De Paola I., Viola A., Biondi B., Badocco D., Formaggio F., Ricci A., Cabri W
doi: Liang Q, Wang K, Shariful I, Ye X, Zhang C
The most common side effects are gastrointestinal issues such as nausea and constipation
Objective To conduct a systematic review and quantitatively assess whether the usage of GLP-1RA is associated with the increased risk of having depression-related adverse events and to learn more about the sources of heterogeneity
There is no absolute contraindication to using GLP-1 receptor agonists in patients with Hashimoto's disease or established hypothyroidism
Additionally, patients who self-dose but never increase their dose beyond an initial level often plateau because they've reached their body's adaptation threshold at that dose